[Impact of the removal of A2 test erythrocytes and the anti-AB reactant on the interpretation of the ABO blood grouping].
This work evaluates the impact of the removal of the anti-AB reagents and A2 test-red blood cells on the interpretation of ABO blood grouping. The first step of the work was a multicentric study concerning the interpretation of "all coming" blood groupings, reporting the results of 105 195 ABO blood groupings of donors and patients carried out on microplates using an automated or a half-automated technique. Their interpretation was performed following four different methods, in order to appreciate the impact on the results of the removal of either anti-AB test-serum, A2 test-red blood cells, or the combination of both. Moreover, a qualitative and quantitative analysis of the interpretations of the blood groupings that were initially not performed (rejections), was carried out in order to determine the most often implied reagent and to quantify a possible gain in interpretation after removing it. A complementary study of the same type concerning more specifically weak ABO phenotypes was carried out to evaluate, in terms of sanitary risks, the consequences of a possible non-interpretation of these phenotypes in patients who would be potential receivers of blood cell products, and in blood donors.